Functional characterization of a novel JPH2 variant (p.R160H) associated with dilated cardiomyopathy

Dilated cardiomyopathy (DCM) is a genetic cardiac disorder characterized by ventricular dilation and systolic dysfunction. Mutations in calcium-handling genes such as JPH2, which plays a critical role in maintaining cardiac dyad integrity, have been associated with DCM. Although more than 20 JPH2 variants have been reported, most lack functional validation. This study investigates the ClinVar-listed JPH2 p.R160H variant and provides initial cellular evidence related to its pathogenic potential, based on genetic data and stress-response assays. A 33-year-old male with severe DCM (LVEF 26%) and asymptomatic parents underwent trio-based whole-exome sequencing (WES). Rare variants were filtered (MAF < 0.01) and prioritized using ACMG guidelines. The JPH2 p.R160H variant was cloned and transfected into AC16 cardiomyocytes. Protein expression levels of MYH7, α-SMA, and TGF-β were assessed by Western blotting. Evolutionary conservation of R160 was evaluated using ClustalX. Trio-based WES identified a de novo JPH2 p.R160H variant absent in both parents and population controls. AC16 cells expressing the mutant construct showed increased levels of myocardial stress markers (MYH7, α-SMA, and TGF-β). JPH2 protein expression was also elevated, indicating possible dysregulation of protein turnover or stability. Evolutionary analysis confirmed that R160 is highly conserved across species. According to ACMG criteria (PS2, PS3, PM2, PP4), the variant was classified as pathogenic. This study provides preliminary cellular evidence supporting the pathogenic potential of the JPH2 p.R160H variant, while the direct effects on calcium handling and dyad integrity remain unknown.The combined genetic and cellular data contribute to more accurate variant classification and support the inclusion of JPH2 in cardiomyopathy genetic screening. Further mechanistic studies—particularly those assessing calcium handling—are warranted to elucidate the broader functional impact of this variant.

Authors

Institutions

Publication Details

Journal
BMC Cardiovascular Disorders
Published
2025-12-20
DOI
https://doi.org/10.1186/s12872-025-05443-8
Primary Topic
Cardiomyopathy and Myosin Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Functional characterization of a novel JPH2 variant (p.R160H) associated with dilated cardiomyopathy

KeWei Gong, Yong Luo, Ruilin Liu, Li Xie et al.
BMC Cardiovascular Disorders
Cardiomyopathy and Myosin Studies
article

Functional characterization of a novel JPH2 variant (p.R160H) associated with dilated cardiomyopathy

KeWei Gong, Yong Luo, Ruilin Liu, Li Xie, Kai Jiao, Yao Yao, Lei Wang
article en

Abstract

Dilated cardiomyopathy (DCM) is a genetic cardiac disorder characterized by ventricular dilation and systolic dysfunction. Mutations in calcium-handling genes such as JPH2, which plays a critical role in maintaining cardiac dyad integrity, have been associated with DCM. Although more than 20 JPH2 variants have been reported, most lack functional validation. This study investigates the ClinVar-listed JPH2 p.R160H variant and provides initial cellular evidence related to its pathogenic potential, based on genetic data and stress-response assays. A 33-year-old male with severe DCM (LVEF 26%) and asymptomatic parents underwent trio-based whole-exome sequencing (WES). Rare variants were filtered (MAF < 0.01) and prioritized using ACMG guidelines. The JPH2 p.R160H variant was cloned and transfected into AC16 cardiomyocytes. Protein expression levels of MYH7, α-SMA, and TGF-β were assessed by Western blotting. Evolutionary conservation of R160 was evaluated using ClustalX. Trio-based WES identified a de novo JPH2 p.R160H variant absent in both parents and population controls. AC16 cells expressing the mutant construct showed increased levels of myocardial stress markers (MYH7, α-SMA, and TGF-β). JPH2 protein expression was also elevated, indicating possible dysregulation of protein turnover or stability. Evolutionary analysis confirmed that R160 is highly conserved across species. According to ACMG criteria (PS2, PS3, PM2, PP4), the variant was classified as pathogenic. This study provides preliminary cellular evidence supporting the pathogenic potential of the JPH2 p.R160H variant, while the direct effects on calcium handling and dyad integrity remain unknown.The combined genetic and cellular data contribute to more accurate variant classification and support the inclusion of JPH2 in cardiomyopathy genetic screening. Further mechanistic studies—particularly those assessing calcium handling—are warranted to elucidate the broader functional impact of this variant.

BMC Cardiovascular DisordersVol. 26(1)
Central South University (CN), Second Xiangya Hospital of Central South University (CN)
Openalex Percentile: Top 42%
Cardiomyopathy and Myosin Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.